Key result
Pretreatment with angiotensin II antagonists, prostaglandin synthetase inhibitors, or propranolol did not alter the constancy of GFR and RBF during decreases in renal arterial pressure in dog kidneys.
Why the study?
Does pretreatment with angiotensin II antagonists, prostaglandin synthetase inhibitors, or beta-blockers affect renal autoregulation of GFR and RBF in dog kidneys?
Does pretreatment with angiotensin II antagonists, prostaglandin synthetase inhibitors, or beta-blockers affect renal autoregulation of GFR and RBF in dog kidneys?
Angiotensin II, prostaglandins, and intrarenal beta receptors do not appear to mediate renal autoregulation of GFR or total RBF in dog kidneys.
Answers are grounded in this paper and cite their sources.
No mediation by these systems in canine autoregulation; leaves open their relevance in human kidneys or disease.
The role of the renin-angiotensin system and prostaglandins in renal autoregulation was investigated in dog kidneys in situ. Renal autoregulation during decreases in renal arterial pressure (RAP) was examined in animals pretreated with a competitive antagonist of angiotensin ii, [1-sarcosine, 8-glycine] angiotensin II, or one of two chemically dissimilar inhibitors of prostaglandin synthetase, indomethacin and meclofenamate. Because of recent evidence suggesting a role for an intrarenal beta receptor in regulating renin release, renal autoregulation was also examined in animals treated with the beta-adrenergic blocking agent propranolol. In all groups of animals constancy of glomerular filtration rate (GFR) and renal blood flow (RBF) was observed after substantial decreases in RAP to a range of 70-90 mmHg. These studies therefore do not provide evidence in support of a role for angiotensin II, prostaglandins, or an intrarenal beta receptor as mediators of the renal autoregulation of GFR or total RBF.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (1975) studied Renal autoregulation. Angiotensin II antagonist, prostaglandin synthetase inhibitors (indomethacin, meclofenamate), or propranolol was evaluated on Constancy of glomerular filtration rate (GFR) and renal blood flow (RBF) after decreases in renal arterial pressure. Pretreatment with angiotensin II antagonists, prostaglandin synthetase inhibitors, or propranolol did not alter the constancy of GFR and RBF during decreases in renal arterial pressure in dog kidneys.
Synapse has enriched 10 related papers. Consider them for comparative context: